Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study: Complementary and alternative medicine in oncology

Claudia Bozza, Lorenzo Gerratana, Debora Basile, Maria Grazia Vitale, Michele Bartoletti, Elisa Agostinetto, Stefania Russo, Alessandro Follador, Elisa De Carlo, Nicoletta Pella, Roberta Sottile, Gianpiero Fasola, Fabio Puglisi

Research output: Contribution to journalArticle

Abstract

Background: It is estimated that about half of cancer patients use at least one form of complementary and alternative medicines (CAM) in their life but there is a strong reticence of patients in talking about CAM with their oncologist. Primary aim of this study was to inform patients about CAM, focusing on their supposed benefits, toxicities and interactions with conventional therapeutic agents. The study also explored patients’ perception about CAM and ascertained the level of CAM use among cancer patients of an Italian academic hospital. Methods: From April 2016 to April 2017, the observational pilot trial “CAMEO-PRO” prospectively enrolled 239 cancer patients that were invited to attend a tutorial about CAM at the Department of oncology, University Hospital of Udine, Italy. Before and after the informative session, patients were asked to fill a questionnaire reporting their knowledge and opinion about CAM. Results: Overall, 163 (70%) women and 70 (30%) men were enrolled. Median age was 61 years. At study entry, 168 (72%) patients declared they had never been interested in this topic previously; 24 patients (11%) revealed the use of a type of alternative therapy and 58 (28%) revealed the use of complementary therapy. In total, 139 (55.2%) patients attended the informative session. Bowker’s test of symmetry demonstrated statistically significant opinion’s change after the session on 9 out of 14 explored items. Conclusions: Informative sessions seem to have a relevant impact on patients’ perceptions and opinions about CAM.

Original languageEnglish
Pages (from-to)2029-2047
Number of pages19
JournalJournal of Cancer Research and Clinical Oncology
Volume144
Issue number10
DOIs
Publication statusPublished - Oct 1 2018

Fingerprint

Complementary Therapies
Neoplasms

Keywords

  • Alternative medicine
  • Communication in oncology
  • Complementary and alternative medicine
  • Quackery
  • Supportive care

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Use and perception of complementary and alternative medicine among cancer patients : the CAMEO-PRO study: Complementary and alternative medicine in oncology. / Bozza, Claudia; Gerratana, Lorenzo; Basile, Debora; Vitale, Maria Grazia; Bartoletti, Michele; Agostinetto, Elisa; Russo, Stefania; Follador, Alessandro; De Carlo, Elisa; Pella, Nicoletta; Sottile, Roberta; Fasola, Gianpiero; Puglisi, Fabio.

In: Journal of Cancer Research and Clinical Oncology, Vol. 144, No. 10, 01.10.2018, p. 2029-2047.

Research output: Contribution to journalArticle

Bozza, C, Gerratana, L, Basile, D, Vitale, MG, Bartoletti, M, Agostinetto, E, Russo, S, Follador, A, De Carlo, E, Pella, N, Sottile, R, Fasola, G & Puglisi, F 2018, 'Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study: Complementary and alternative medicine in oncology', Journal of Cancer Research and Clinical Oncology, vol. 144, no. 10, pp. 2029-2047. https://doi.org/10.1007/s00432-018-2709-2
Bozza, Claudia ; Gerratana, Lorenzo ; Basile, Debora ; Vitale, Maria Grazia ; Bartoletti, Michele ; Agostinetto, Elisa ; Russo, Stefania ; Follador, Alessandro ; De Carlo, Elisa ; Pella, Nicoletta ; Sottile, Roberta ; Fasola, Gianpiero ; Puglisi, Fabio. / Use and perception of complementary and alternative medicine among cancer patients : the CAMEO-PRO study: Complementary and alternative medicine in oncology. In: Journal of Cancer Research and Clinical Oncology. 2018 ; Vol. 144, No. 10. pp. 2029-2047.
@article{1b2ecc23b8c1444f911ff211c8951b2d,
title = "Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study: Complementary and alternative medicine in oncology",
abstract = "Background: It is estimated that about half of cancer patients use at least one form of complementary and alternative medicines (CAM) in their life but there is a strong reticence of patients in talking about CAM with their oncologist. Primary aim of this study was to inform patients about CAM, focusing on their supposed benefits, toxicities and interactions with conventional therapeutic agents. The study also explored patients’ perception about CAM and ascertained the level of CAM use among cancer patients of an Italian academic hospital. Methods: From April 2016 to April 2017, the observational pilot trial “CAMEO-PRO” prospectively enrolled 239 cancer patients that were invited to attend a tutorial about CAM at the Department of oncology, University Hospital of Udine, Italy. Before and after the informative session, patients were asked to fill a questionnaire reporting their knowledge and opinion about CAM. Results: Overall, 163 (70{\%}) women and 70 (30{\%}) men were enrolled. Median age was 61 years. At study entry, 168 (72{\%}) patients declared they had never been interested in this topic previously; 24 patients (11{\%}) revealed the use of a type of alternative therapy and 58 (28{\%}) revealed the use of complementary therapy. In total, 139 (55.2{\%}) patients attended the informative session. Bowker’s test of symmetry demonstrated statistically significant opinion’s change after the session on 9 out of 14 explored items. Conclusions: Informative sessions seem to have a relevant impact on patients’ perceptions and opinions about CAM.",
keywords = "Alternative medicine, Communication in oncology, Complementary and alternative medicine, Quackery, Supportive care",
author = "Claudia Bozza and Lorenzo Gerratana and Debora Basile and Vitale, {Maria Grazia} and Michele Bartoletti and Elisa Agostinetto and Stefania Russo and Alessandro Follador and {De Carlo}, Elisa and Nicoletta Pella and Roberta Sottile and Gianpiero Fasola and Fabio Puglisi",
year = "2018",
month = "10",
day = "1",
doi = "10.1007/s00432-018-2709-2",
language = "English",
volume = "144",
pages = "2029--2047",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Use and perception of complementary and alternative medicine among cancer patients

T2 - the CAMEO-PRO study: Complementary and alternative medicine in oncology

AU - Bozza, Claudia

AU - Gerratana, Lorenzo

AU - Basile, Debora

AU - Vitale, Maria Grazia

AU - Bartoletti, Michele

AU - Agostinetto, Elisa

AU - Russo, Stefania

AU - Follador, Alessandro

AU - De Carlo, Elisa

AU - Pella, Nicoletta

AU - Sottile, Roberta

AU - Fasola, Gianpiero

AU - Puglisi, Fabio

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Background: It is estimated that about half of cancer patients use at least one form of complementary and alternative medicines (CAM) in their life but there is a strong reticence of patients in talking about CAM with their oncologist. Primary aim of this study was to inform patients about CAM, focusing on their supposed benefits, toxicities and interactions with conventional therapeutic agents. The study also explored patients’ perception about CAM and ascertained the level of CAM use among cancer patients of an Italian academic hospital. Methods: From April 2016 to April 2017, the observational pilot trial “CAMEO-PRO” prospectively enrolled 239 cancer patients that were invited to attend a tutorial about CAM at the Department of oncology, University Hospital of Udine, Italy. Before and after the informative session, patients were asked to fill a questionnaire reporting their knowledge and opinion about CAM. Results: Overall, 163 (70%) women and 70 (30%) men were enrolled. Median age was 61 years. At study entry, 168 (72%) patients declared they had never been interested in this topic previously; 24 patients (11%) revealed the use of a type of alternative therapy and 58 (28%) revealed the use of complementary therapy. In total, 139 (55.2%) patients attended the informative session. Bowker’s test of symmetry demonstrated statistically significant opinion’s change after the session on 9 out of 14 explored items. Conclusions: Informative sessions seem to have a relevant impact on patients’ perceptions and opinions about CAM.

AB - Background: It is estimated that about half of cancer patients use at least one form of complementary and alternative medicines (CAM) in their life but there is a strong reticence of patients in talking about CAM with their oncologist. Primary aim of this study was to inform patients about CAM, focusing on their supposed benefits, toxicities and interactions with conventional therapeutic agents. The study also explored patients’ perception about CAM and ascertained the level of CAM use among cancer patients of an Italian academic hospital. Methods: From April 2016 to April 2017, the observational pilot trial “CAMEO-PRO” prospectively enrolled 239 cancer patients that were invited to attend a tutorial about CAM at the Department of oncology, University Hospital of Udine, Italy. Before and after the informative session, patients were asked to fill a questionnaire reporting their knowledge and opinion about CAM. Results: Overall, 163 (70%) women and 70 (30%) men were enrolled. Median age was 61 years. At study entry, 168 (72%) patients declared they had never been interested in this topic previously; 24 patients (11%) revealed the use of a type of alternative therapy and 58 (28%) revealed the use of complementary therapy. In total, 139 (55.2%) patients attended the informative session. Bowker’s test of symmetry demonstrated statistically significant opinion’s change after the session on 9 out of 14 explored items. Conclusions: Informative sessions seem to have a relevant impact on patients’ perceptions and opinions about CAM.

KW - Alternative medicine

KW - Communication in oncology

KW - Complementary and alternative medicine

KW - Quackery

KW - Supportive care

UR - http://www.scopus.com/inward/record.url?scp=85050596760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050596760&partnerID=8YFLogxK

U2 - 10.1007/s00432-018-2709-2

DO - 10.1007/s00432-018-2709-2

M3 - Article

VL - 144

SP - 2029

EP - 2047

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 10

ER -